News & Analysis as of

TikTok iPhone

Dunlap Bennett & Ludwig PLLC

“Why Can’t We Just Ban It?”: Legal, Political, And Technological Difficulties With Banning Tiktok

This article is the second article in a three-part series. The first article detailed the procedural posture of the failed executive actions to create a TikTok ban. This article discusses the current Congressional attempt to...more

Robins Kaplan LLP

Financial Daily Dose 10.19.2020 | Top Story: ConocoPhillips Buys Oil Producer Concho Resources in Deal Worth Nearly $10B

Robins Kaplan LLP on

ConocoPhillips is doubling down on its commitment to the Midland basin by buying Concho Resources Inc. in “an all-stock transaction valued at $9.7 billion,” even “as the American shale-drilling industry is facing a downturn...more

Robins Kaplan LLP

Financial Daily Dose 9.15.2020 | Top Story: Citi Faces Federal Risk-Management Inquiry, Resumes Job Cuts

Robins Kaplan LLP on

Federal authorities are prepping to “reprimand Citigroup Inc. for failing to improve its risk-management systems—an expansive set of technology and procedures designed to detect problematic transactions, risky trades and...more

Robins Kaplan LLP

Financial Daily Dose 8.27.2020 | Top Story: TikTok CEO Resigns After Just 4 Months on Job

Robins Kaplan LLP on

Still-new TIkTok CEO Kevin Mayer has stepped down, “just months after taking the helm of the viral short video app.” ByteDance had appointed Mayer in May in an effort “to make the case that TikTok operates as a separate...more

Robins Kaplan LLP

Financial Daily Dose 8.3.2020 | Top Story: Microsoft in Talks to Acquire ByteDance’s U.S. TikTok Operations

Robins Kaplan LLP on

Following recent histrionics from the White House, ByteDance, “the Chinese internet giant that owns TikTok, has offered to sell all of the popular video app’s American operations as a way to save the business from being...more

Robins Kaplan LLP

Financial Daily Dose 7.10.2020 | Top Story: Gilead Reports Strong Remdesivir Results

Robins Kaplan LLP on

Gilead Sciences Inc. reports that its remdesivir virus treatment has been positively correlated with a 62% reduction in death risks compared with the standard of care in an initial analysis....more

6 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide